According to research, the expression of natural killer group 2 member A (NKG2A) of the NK cell receptor is up-regulated in the peripheral blood of colon cancer patients, and the monitoring and killing capabilities of NK cells are blocked, resulting in the immune escape of colon cancer cells (47). Here, KLRD1 is linked to malignant colon neoplasm.